Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.
about
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophyDisruption of the Saccharomyces cerevisiae FAT1 gene decreases very long-chain fatty acyl-CoA synthetase activity and elevates intracellular very long-chain fatty acid concentrations.X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.Nerve conduction studies in adrenomyeloneuropathy.Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy.High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders.Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient micePathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblastsThe Roles of β-Oxidation and Cofactor Homeostasis in Peroxisome Distribution and Function in Arabidopsis thaliana.Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.Influence of zinc deficiency on cell-membrane fluidity in Jurkat, 3T3 and IMR-32 cells.Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy.
P2860
Q24300003-ED511546-A58E-4C0D-9DEA-7DDAB9B1A45EQ27932646-228D96DC-1629-41E9-B350-3C04D35613CAQ30460666-313DE19F-6428-4857-B78F-4B7EAA04489AQ33735461-0EBEA104-D38C-4AA3-BF4E-F751743F49CBQ33882324-222E8289-DFD3-4716-930F-2C38354D93D0Q34184775-4DAC217E-90C2-4078-A7BB-71425C4CFC94Q34257373-63F39CAA-DB8F-49BD-A383-ED706839A443Q34491978-66D22972-551B-4709-ABC0-CEAE8B1428CAQ34513788-A25307E3-0B6E-4458-BAAF-750D54D509E2Q35417932-60E21239-CDBD-4929-834F-960888DF4108Q35585150-5388DF6F-7706-4F53-BA1E-5D5F8DB5DF8DQ37347171-5914A276-41BA-4B60-810F-946A33E0E183Q38823505-B18D0ADA-1809-4135-9A89-694C030BE016Q38867787-22099663-3DAE-450A-9DB0-05A34E70CE31Q41776462-295704F3-4BA5-4B02-9DD3-5804FA9D9216Q41972280-5FE8DDC3-83FE-4904-9243-C3DC54E712AA
P2860
Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.
description
1983 nî lūn-bûn
@nan
1983 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@ast
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@en
type
label
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@ast
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@en
prefLabel
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@ast
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@en
P2093
P2860
P356
P1476
Membrane microviscosity is inc ...... phy and adrenomyeloneuropathy.
@en
P2093
P2860
P304
P356
10.1172/JCI110963
P407
P577
1983-07-01T00:00:00Z